Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-03-13

Clinical Trial Update: Nalbuphine in ARDS Patients After Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating nalbuphine in patients with acute respiratory distress syndrome after surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nalbuphine (nalbuphine)

Snippet

Sponsor: Hairong Chen | Conditions: Acute Respiratory Distress Syndrome | Phase 4 | Status: RECRUITING